Supreme Court Hears Oral Arguments on FCA Scienter in Drug Pricing Fraud Action
- April 21, 2023
The U.S. Supreme Court heard oral arguments April 18 involving a pair of Seventh Circuit decisions that rejected qui tam actions under the False Claims Act (FCA) for failing to establish scienter under the statute.
ARTICLE TAGS
You must be logged in to access this content.